Century Capital Management LLC lowered its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 90,726 shares of the company’s stock after selling 5,034 shares during the period. Century Capital Management LLC owned 0.10% of Acadia Healthcare worth $4,480,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. Alliancebernstein L.P. increased its holdings in shares of Acadia Healthcare by 66.0% during the 2nd quarter. Alliancebernstein L.P. now owns 65,453 shares of the company’s stock worth $3,232,000 after acquiring an additional 26,023 shares during the last quarter. HPM Partners LLC increased its holdings in shares of Acadia Healthcare by 22.8% during the 2nd quarter. HPM Partners LLC now owns 33,551 shares of the company’s stock worth $1,657,000 after acquiring an additional 6,236 shares during the last quarter. AGF Investments Inc. acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth approximately $4,941,000. Atlantic Trust Group LLC increased its holdings in shares of Acadia Healthcare by 5.0% during the 2nd quarter. Atlantic Trust Group LLC now owns 250,557 shares of the company’s stock worth $12,372,000 after acquiring an additional 11,848 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth approximately $551,000.
ILLEGAL ACTIVITY NOTICE: “Century Capital Management LLC Decreases Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)” was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://ledgergazette.com/2017/09/16/acadia-healthcare-company-inc-achc-position-lowered-by-century-capital-management-llc.html.
In other news, EVP Christopher L. Howard sold 53,713 shares of the business’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $2,722,711.97. Following the sale, the executive vice president now directly owns 147,286 shares of the company’s stock, valued at $7,465,927.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Reeve B. Waud sold 50,000 shares of the business’s stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $47.51, for a total transaction of $2,375,500.00. The disclosure for this sale can be found here. Insiders sold 3,185,693 shares of company stock worth $162,606,599 over the last ninety days. Corporate insiders own 11.10% of the company’s stock.
ACHC has been the topic of a number of recent analyst reports. William Blair initiated coverage on Acadia Healthcare in a report on Tuesday, July 18th. They set an “outperform” rating on the stock. Jefferies Group LLC set a $55.00 target price on Acadia Healthcare and gave the stock a “buy” rating in a report on Thursday, June 1st. BidaskClub lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, August 18th. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $53.00 target price on the stock in a report on Wednesday, June 28th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $51.00 price objective on shares of Acadia Healthcare in a report on Thursday, June 1st. One investment analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Acadia Healthcare currently has an average rating of “Buy” and a consensus target price of $58.69.
Acadia Healthcare Company, Inc. (NASDAQ ACHC) traded down 4.06% during mid-day trading on Friday, hitting $46.78. The stock had a trading volume of 1,814,213 shares. Acadia Healthcare Company, Inc. has a 12 month low of $32.54 and a 12 month high of $54.34. The firm’s 50-day moving average is $48.96 and its 200 day moving average is $45.91. The company has a market cap of $4.11 billion, a price-to-earnings ratio of 514.07 and a beta of 1.14.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. During the same period in the previous year, the company earned $0.73 earnings per share. The business’s revenue for the quarter was down 5.4% on a year-over-year basis. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current fiscal year.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.